Jingjing Duan

Fuxing Road 28
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2.

Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2.

Journal: Journal of gastroenterology
Published: November 24, 2025

The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.

The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center.

Journal: BMC cancer
Published: September 07, 2024

Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study.

Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study.

Journal: Oncology
Published: July 12, 2024

Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.

Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.

Journal: Nature communications
Published: June 30, 2024

Circulating immune cell profile in patients with colorectal cancer.

Circulating immune cell profile in patients with colorectal cancer.

Journal: The British journal of surgery
Published: June 11, 2024

Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs.

Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs.

Journal: iScience
Published: April 28, 2024

Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma.

Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: March 17, 2024

Exosomal miR-224-3p promotes lymphangiogenesis and lymph node metastasis by targeting GSK3B in gastric cancer.

Exosomal miR-224-3p promotes lymphangiogenesis and lymph node metastasis by targeting GSK3B in gastric cancer.

Journal: Oncology research
Published: February 02, 2024

Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.

Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.

Journal: BMC cancer
Published: August 26, 2023

Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.

Journal: BMC cancer
Published: July 15, 2023

The dCache Domain of the Chemoreceptor Tlp1 in Campylobacter jejuni Binds and Triggers Chemotaxis toward Formate.

The dCache Domain of the Chemoreceptor Tlp1 in Campylobacter jejuni Binds and Triggers Chemotaxis toward Formate.

Journal: mBio
Published: April 13, 2023

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.

Journal: BMC cancer
Published: March 06, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026